Clinical Rheumatology is an international English-language journal devoted to publishing original clinical investigation and research in the general field of rheumatology with accent on clinical aspects at postgraduate level.
The journal succeeds Acta Rheumatologica Belgica, originally founded in 1945 as the official journal of the Belgian Rheumatology Society. Clinical Rheumatology aims to cover all modern trends in clinical and experimental research as well as the management and evaluation of diagnostic and treatment procedures connected with the inflammatory, immunologic, metabolic, genetic and degenerative soft and hard connective tissue diseases.
Why publish with us
- Published in partnership with the International League of Associations for Rheumatology (ILAR), we welcome articles covering research, diagnosis and treatment of rheumatological conditions, with a special emphasis on clinical aspects.
- Our international and committed editorial team offers a rigorous yet swift review process, providing a first decision in under 5 weeks on average.
- We provide high levels of author satisfaction, with 98% of our published authors reporting that they would definitely or probably publish with us again.
- Through Springer Compact agreements, authors from participating institutions can publish Open Choice at no cost to the authors.
Journal information
- Editor-in-Chief
-
- Carlos Pineda
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 2.394 (2019)
- Impact factor
- 2.380 (2019)
- Five year impact factor
- 28 days
- Submission to first decision
- 83 days
- Submission to acceptance
- 760,550 (2020)
- Downloads
Latest issue
Latest articles
-
-
HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu’s arteritis
Authors (first, second and last of 10)
-
-
-
Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
Authors (first, second and last of 4)
Journal updates
-
Editor Highlights - April 2021
Prof. Carlos Pineda provides his Editor-in-Chief highlights from this issue.
-
Editor Highlights - March 2021
Prof. Carlos Pineda provides his Editor-in-Chief highlights from this issue.
-
Editor Highlights - February 2021
Prof. Carlos Pineda provides his Editor-in-Chief highlights from this issue.
-
Editor Highlights - January 2021
Prof. Carlos Pineda provides his Editor-in-Chief highlights from this issue.
Societies, partners and affiliations
About this journal
- Electronic ISSN
- 1434-9949
- Print ISSN
- 0770-3198
- Abstracted and indexed in
-
- AGRICOLA
- ANVUR
- CAB Abstracts
- CNKI
- Current Contents/Clinical Medicine
- Dimensions
- EBSCO Academic Search
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EBSCO STM Source
- EMBASE
- Elsevier Biobase
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Health & Medical Collection
- ProQuest Health Research Premium Collection
- ProQuest Immunology Abstracts
- ProQuest Medical Database
- ProQuest Natural Science Collection
- ProQuest Pharma Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© International League of Associations for Rheumatology (ILAR)